Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab

PURPOSE: To report the visual and anatomic outcomes in eyes with macular oedema (MO) secondary to central retinal vein occlusion (CRVO) that were switched from either intravitreal bevacizumab or ranibizumab to intravitreal aflibercept. METHODS: Two-center retrospective chart review. Eyes with MO sec...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eye (Lond)
Main Authors: Papakostas, T D, Lim, L, van Zyl, T, Miller, J B, Modjtahedi, B S, Andreoli, C M, Wu, D, Young, L H, Kim, I K, Vavvas, D G, Esmaili, D D, Husain, D, Eliott, D, Kim, L A
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2016
Fag:
Clinical Study
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4709525/
https://ncbi.nlm.nih.gov/pubmed/26449196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2015.175
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker